Quebec-based cannabis firm HEXO (TSX:HEXO,NYSE:HEXO) announced that CFO Michael Monahan stepped down from his executive role on Friday (October 4) after taking the position in May.

In a statement released shortly after trading hours on Friday, the former HEXO executive said he decided to leave the firm for family reasons, but will stay on as a consultant during the transition period.

“It has become apparent that this job requires me to spend the majority of my time in Gatineau and in Ottawa,” said Monahan. “This isn’t possible for me at this time given my family’s needs, and so I have decided to resign.”

Company shares fell 5.7 percent after trading hours on Friday, opening at C$5.11 on Monday (October 7).

In late May, Monahan’s appointment as CFO also came along with the establishment of HEXO USA in Delaware to help formalize the company’s presence in the US.

Monahan has been succeeded by Stephen Burwash, former vice president of strategic finance at HEXO. Burwash previously held the role of interim CFO prior to Monahan’s appointment after HEXO’s then-CFO Ed Chaplin confirmed he would also be transitioning out of the company.

The abrupt departure of Monahan raised some questions in the market about what’s happening behind the scenes at the marijuana producer.

It has also resulted in Bank of America Merrill Lynch downgrading the stock to a price target of C$4, less than half of its previous price target of C$9.

According to Bloomberg, Merrill Lynch analyst Christopher Carey wrote in a note to investors that there is no real way to know the expectations Monahan faced when he came into the role; nevertheless, his hasty resignation is a “concerning” marker of the inner workings of the company.

“We think it’s reasonable to assume the corporate finance organization was less developed than what Monahan had realized, perhaps indicating there remains much work to professionalizing said organization than what he (or the Street) fully appreciated,” wrote Carey.

The company saw another drop after the June release of its third quarter results, which missed the mark for some analysts.

HEXO reported C$13 million in net revenue for the period, up significantly from C$1.2 million in the same quarter last year, but BNN Bloomberg said that analysts expected revenues of C$14 million.

In a note to clients, RBC Capital Markets analyst Douglas Miehm said HEXO’s results were “a little light” when compared to estimates. Miehm did go on to note that the variance between RBC’s estimate and HEXO’s quarterly report was driven by the company’s performance in the medical business; adult-use segment results were in line with the RBC’s expectations.

Analyst consensus on TipRanks has the stock listed as a “moderate sell” with a price target of C$6.42, representing about a 26 percent upside over the current share price.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less